Parallel Advisors’s CollPlant Biotechnologies CLGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.43K | Hold |
3,254
| – | – | ﹤0.01% | 2759 |
|
|
2025
Q1 | $8.39K | Buy |
3,254
+1
| +0% | +$3 | ﹤0.01% | 2489 |
|
|
2024
Q4 | $11.7K | Hold |
3,253
| – | – | ﹤0.01% | 2339 |
|
|
2024
Q3 | $16.2K | Sell |
3,253
-1
| -0% | -$5 | ﹤0.01% | 2185 |
|
|
2024
Q2 | $16.2K | Sell |
3,254
-824
| -20% | -$4.1K | ﹤0.01% | 2083 |
|
|
2024
Q1 | $21.8K | Buy |
4,078
+4,007
| +5,644% | +$21.4K | ﹤0.01% | 1931 |
|
|
2023
Q4 | $454 | Sell |
71
-8,485
| -99% | -$54.3K | ﹤0.01% | 3071 |
|
|
2023
Q3 | $47.7K | Sell |
8,556
-1,058
| -11% | -$5.89K | ﹤0.01% | 1418 |
|
|
2023
Q2 | $78.5K | Hold |
9,614
| – | – | ﹤0.01% | 1187 |
|
|
2023
Q1 | $67.5K | Sell |
9,614
-3,025
| -24% | -$21.2K | ﹤0.01% | 1226 |
|
|
2022
Q4 | $106K | Sell |
12,639
-3,743
| -23% | -$31.3K | ﹤0.01% | 970 |
|
|
2022
Q3 | $111K | Hold |
16,382
| – | – | 0.01% | 918 |
|
|
2022
Q2 | $131K | Hold |
16,382
| – | – | 0.01% | 855 |
|
|
2022
Q1 | $192K | Sell |
16,382
-3,684
| -18% | -$43.2K | 0.01% | 748 |
|
|
2021
Q4 | $328K | Sell |
20,066
-1,228
| -6% | -$20.1K | 0.01% | 574 |
|
|
2021
Q3 | $360K | Buy |
21,294
+16,995
| +395% | +$287K | 0.01% | 505 |
|
|
2021
Q2 | $91K | Sell |
4,299
-823
| -16% | -$17.4K | ﹤0.01% | 964 |
|
|
2021
Q1 | $69K | Buy |
5,122
+1,934
| +61% | +$26.1K | ﹤0.01% | 1025 |
|
|
2020
Q4 | $34K | Buy |
+3,188
| New | +$34K | ﹤0.01% | 1240 |
|